Skip to main content
OpenTrials

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

1,104 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)

NCT03617367

Conditions
Cervical Dystonia, Dyskinesias, Dystonia, +4 more
Locations
  • HOPE Research Institute Phoenix, Arizona, United States
  • Movement Disorders Center of Arizona Scottsdale, Arizona, United States
  • The Parkinsons and Movement Disorder Institute Fountain Valley, California, United States
  • Loma Linda University Loma Linda, California, United States
View all 65 locations
View Trial Details
Completed

Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)

NCT02535884

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • CHU Amiens Hôpital nord, Department of neurosurgery and Department of neurology Amiens, France
  • Hôpital Roger Salengro, Service de Neurologie et Pathologie du mouvement Lille, France
  • Charité Campus Virchow Klinikum Berlin, Germany
View Trial Details
Completed

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

NCT01584440

Conditions
Aberrant Motor Behavior in Dementia, Aggression, Agitation, +20 more
Locations
  • Phoenix, Arizona, United States
  • Sun City, Arizona, United States
  • Fresno, California, United States
  • Fullerton, California, United States
View all 44 locations
View Trial Details
Completed

Alternatives for Reducing Chorea in Huntington Disease

NCT01897896

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Teva Investigational Site 057 Birmingham, Alabama, United States
  • Teva Investigational Site 038 Phoenix, Arizona, United States
  • Teva Investigational Site 298 Fayetteville, Arkansas, United States
  • Teva Investigational Site 052 Englewood, Colorado, United States
View all 38 locations
View Trial Details

Related conditions